Treatment of Neurodevelopmental Disorders: Targeting Neurobiological Mechanisms. Dieser Artikel ist nicht verfügbar.
Sprache: Englisch
Verlag: Oxford University Press, 2014
- Hardcover
- Gebraucht
Anbieter: ThriftBooks-Atlanta, AUSTELL, GA, USAThriftBooks-Atlanta
Verkäufer/-in mit 5 Sternen
Verkäufer:in bei ZVAB seit 24. März 2009
Nicht verfügbar
Hardcover
Zustand: Gebraucht - Gut
EUR 23,41
Artikelbeschreibung des Verkäufers
May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Bestandsnummer des Verkäufers G019993780XI4N00
- Titel
- Treatment of Neurodevelopmental Disorders: Targeting Neurobiological Mechanisms
- Verlag
- Oxford University Press
- Erscheinungsjahr
- 2014
- Zustand
- Very Good
- Schutzumschlag
- No Jacket
- Einband
- Hardcover
- Sprache
- Englisch
- ISBN-10
- 019993780X
- ISBN-13
- 9780199937806
- Artikelgewicht
- 1,6 Pfund
Brings advances in genetics, neurobiology, and psychopharmacology to the clinic to enhance treatment for neurodevelopmental disorders
„Inhaltsangabe“ gehört möglicherweise zu einer anderen Auflage dieses Titels.
Über die Autorin bzw. den Autor
Dr. Randi Hagerman is an expert in the treatment in neurodevelopmental disorders with expertise in targeted treatments that reverse the neurobiological abnormalities associated with a specific disorder. This new age of targeted treatments has led to new interventions which are changing the trajectories of development for many of these children.
Dr. Robert Hendren is a psychiatrist who focuses on the diagnosis and treatment of neurodevelopmental disorders including autism. His research has spanned a variety of illnesses, from autism, schizophrenia and bipolar disorder to eating and impulse control disorders. In 2001 he became diretor of the MIND Institute at the University of California, Davis. where he developed a strong clinical trials program that has tested many new treatments for autism. Since 2009 as director of child and adolescent psychiatry at UCSF.
Dr. Robert Hendren is a psychiatrist who focuses on the diagnosis and treatment of neurodevelopmental disorders including autism. His research has spanned a variety of illnesses, from autism, schizophrenia and bipolar disorder to eating and impulse control disorders. In 2001 he became diretor of the MIND Institute at the University of California, Davis. where he developed a strong clinical trials program that has tested many new treatments for autism. Since 2009 as director of child and adolescent psychiatry at UCSF.
„Über diesen Titel“ gehört möglicherweise zu einer anderen Auflage dieses Titels.